Argonaut Blog & News
When is the Right Time to Select a Biotech Contract Manufacturer (CMO)?
Every journey to contract manufacturing is unique. Some biotech companies know, at the start, they want to work with a contract manufacturing organization (CMO), while others choose to engage a CMO later in the product design process or even after pr [...]
Make Versus Buy: Evaluating your Aseptic Fill/Finish Manufacturing Strategy
Every biopharma company is eventually faced with the “make versus buy” decision – should they fill/finish their drug product in-house or outsource? Complicating things further, a third option also exists to outsource a portion while retaining some i [...]
Scale-up and Automation Strategies in Life Science Manufacturing
Scale-up and automation in life science manufacturing is challenging. When picturing a manufacturing line, you likely conjure up images of automated multi-function equipment or deft robotic arms. However, for the vast majority of life science compani [...]
Protecting Your Life Science Cold Chain From Styrofoam Bans
Life science companies, from reagents to diagnostics, rely on cold chain shipping. A vital component in the chain is the ubiquitous polystyrene cooler. Yet, with restaurant polystyrene bans growing in prevalence, it is likely a matter of time before [...]
Strategic plays to grow your biotech startup
Being a biotech startup is exciting. Your company is young, energetic, and full of potential. However, your company is likely lacking in two key areas: cash and time. Startups have the difficult task of scaling quickly to profitability, while trying [...]
New manufacturing strategies for the precision medicine future
Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value, both for patients and themselves. [...]
How QSR-Compliant Medical Device Companies Can Switch to ISO 13485:2016
For decades, there has been a divide in the medical device regulatory landscape. While the U.S. Food and Drug Administration (FDA) has considered their Quality System Regulation (QSR) to be the minimum criteria for medical device manufacturing since [...]
Our top picks for BIO International 2019
The 2019 BIO International conference is only one week away! Here at Argonaut, our team is preparing for a week filled with partnership meetings and exciting talks. This year a major conference focus is on rare diseases and precision medicine. With t [...]
Selecting the Right CDMO Partner – Three Keys to Success
Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With [...]
Mission Bio Partners With LabCorp to Accelerate Targeted Drug Development with Single-Cell Genomics
Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and companion diagnostics de [...]